Applied Genetic (AGTC) Key Ratios

$0.39

$0.00 (0.00%)

As on 09-Dec-2022 09:30EDT

Market cap

info icon

$27 Mln

Revenue (TTM)

info icon

$0 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

1.5

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -35.00 -77.38 -61.41
EBIT 2.14 -5.43 -14.47 -236.18 -295.99
Net Profit -0.13 -7.54 -17.91 -240.12 -267.58
EPS 30.68 28.86 17.03 -39.63 -229.91
Book Value -- -- -74.81 -46.89 -36.62
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMJun-22Jun-21
EBIT-Margin info -11,314.71-6,807.31-21,080.92-20,390.46-11,686.20
Net Margin info -1,279.75-456.12-21,610.46----
Return on equity info -84.89-55.35-217.20-119.60-73.75
Return on Capital info -67.46-44.90---84.99-60.21
Return on Assets info -56.59-37.53-65.01-71.20-50.89
Debt to Equity (x) info ----0.390.760.29
ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Applied Genetic (AGTC)
--
-84.99
-60.21
-57.18
-2.26
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

-217.20

Lower than Peers by 190.88

Profit after tax / Average Net worth * 100

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Applied Genetic (AGTC)
-217.20
-119.60
-73.75
-61.30
-2.26
Peer Median
-26.31
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-65.01

Lower than Peers by 52.05

Profit after tax / Average Total assets * 100

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Applied Genetic (AGTC)
-65.01
-71.20
-50.89
-47.67
-1.90
Peer Median
-12.96
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Margin

-21,080.92

Lower than Peers by 21,021.22

Operating profit (EBIT) / Net Sales * 100

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Applied Genetic (AGTC)
-21,080.92
-20,390.46
-11,686.20
-1,867.47
-4.63
Peer Median
-59.70
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

-21,610.46

Lower than Peers by 21,539.40

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Applied Genetic (AGTC)
-21,610.46
-21,213.23
-11,565.80
-1,279.75
-4.55
Peer Median
-71.06
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Profit Margin

-0.01

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Applied Genetic (AGTC)
-0.01
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Revenue Growth

-35.00

Lower than Peers by 55.56

Year on year growth in net sales

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Applied Genetic (AGTC)
-35.00
-0.35
-0.80
-0.94
0.72
Peer Median
20.56
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EBIT Growth

-14.47

Lower than Peers by 29.67

Year on year growth in operating profit (EBIT)

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Applied Genetic (AGTC)
-14.47
-13.41
-27.55
-2,273.52
90.91
Peer Median
15.20
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-17.91

Lower than Peers by 25.77

Year on year growth in profit after tax

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Applied Genetic (AGTC)
-17.91
-19.22
-26.01
-2,187.74
90.58
Peer Median
7.86
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

17.03

Lower than Peers by 13.42

Year on year growth in earnings per share

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Applied Genetic (AGTC)
17.03
0.13
0.20
-18.61
0.91
Peer Median
30.45
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

-83.21

Lower than Peers by 84.46

Year on year growth in book value per share

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Applied Genetic (AGTC)
-83.21
--
--
--
--
Peer Median
1.25
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Debt to Equity

0.39

--

Total debt / Net worth

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Applied Genetic (AGTC)
0.39
0.76
0.29
0.15
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Applied Genetic (AGTC)
--
0.36
0.04
0.02
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

1.40

Lower than Peers by 2.08

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Applied Genetic (AGTC)
1.40
1.97
5.56
6.40
9.01
Peer Median
3.48
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

1.40

Lower than Peers by 1.89

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Applied Genetic (AGTC)
1.40
--
--
--
--
Peer Median
3.29
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

-25.29

Lower than Peers by 23.78

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Applied Genetic (AGTC)
-25.29
-24.78
-38.80
--
--
Peer Median
-1.51
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

--

--

Debtors outstanding / Net Sales * 100

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Applied Genetic (AGTC)
--
--
--
--
0.03
Peer Median
24.33
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Asset Turnover

0.00

Lower than Peers by 0.23

Sales / Average Total Assets

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Applied Genetic (AGTC)
0.00
0.00
0.00
0.03
0.40
Peer Median
0.23
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Applied Genetic (AGTC)
--
--
--
0.97
0.98
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Applied Genetic (AGTC)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Applied Genetic (AGTC)
--
--
--
--
30.06
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Applied Genetic (AGTC)
--
--
--
--
-29.08
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Applied Genetic (AGTC)
--
-0.50
-2.23
-2.54
-34.01
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

1.51

Lower than Peers by 3.45

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Applied Genetic (AGTC)
1.51
1.18
1.50
1.64
0.87
Peer Median
4.96
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Applied Genetic (AGTC)
--
--
--
--
--
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

-0.19

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Applied Genetic (AGTC)
-0.19
-0.17
-0.82
-1.05
20.97
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

27

Lower than Peers by 57

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Jun-22
Jun-21
Jun-20
Jun-19
Applied Genetic (AGTC)
27
--
--
--
--
Peer Median
83
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...